Fast, Reliable Solutions for Coupling Reactions

Catalyst Screening Services
Accelerate discovery with catalyst screening-quickly identify optimal catalysts, reduce trial-and-error, and boost reaction efficiency to advance your research faster.

Why Choose Medicilon for Catalyst Screening?

Catalyst Screening Service at Medicilon offers high-throughput screening and advanced catalyst optimization to streamline the drug discovery workflow from the cross-coupling reactions to scaling up production. Our expertise in green chemistry and synthetic workflows ensures efficient and sustainable solutions.

Comprehensive Capability

We support all major coupling reactions. Our screening library features an extensive range of commercial and custom-synthesized catalysts and ligands.

State-of-the-Art Infrastructure
  • MIKROUNA Glovebox and CATEC nitrogen cabinet for air-sensitive chemistries
  • High-Throughput Screening (HTS) boxes from Analytical Sales and Services
  • Automated workflows for reproducible results
Rapid Turnaround Times

Our established catalyst screening workflow delivers screening results fast.

  • Standard Service: 72-hour turnaround
  • VIP Service: Results in 48 hours
Comprehensive Capability

Bond Formations

C-C Bond Formation
C-X Bond Formation
Buchwald
UIIman
Miyaura borylation
C-O
C-S

Medicilon’s Proven Catalyst Screening Workflow

Catalyst Screening Services delivers a fast, efficient, and precise workflow to identify and optimize catalysts for your drug discovery and development projects. From reaction design to actionable insights, we ensure high-quality results.

Tumor Models
Xenograft Models (186+)
Humanized Models (30+)
Syngeneic Models (30+)
Orthotopic Models (50+)
PDX Models (100+)
Non-tumor Models
CNS Diseases Models (64+)
Inflammatory & Immune Diseases (32+)
Cardiovascular Diseases (25+)
Metabolic Diseases (39+)
Digestive Diseases Models (18+)
Tumor models:

Medicilon provides a comprehensive range of oncology models, including:

  • CDX Models – Fast, reliable tumor models for early-phase drug screening.
  • PDX Models – Clinically relevant models for personalized medicine research.
 

This holistic approach ensures that researchers can seamlessly transition from early drug discovery to translational research, accelerating the path to clinical trials.

 

Learn more about Medicilon's Workflow Approach

Accelerate your reaction development with Medicilon’s Catalyst Screening Services

Contact Medicilon

Name
Address

Search Medicilon

【White Paper】Navigating the DMPK Gauntlet: A Strategic Analysis of the Interconnected Challenges Shaping the Future of Drug Development

Medicilon: Innovating Globally at CMC-China Expo 2025

Novamab Announces NMPA CDE Approval of IND for LQ036, the World’s First Inhaled Nanobody for Moderate-to-Severe Asthma